Regular follow-up with healthcare providers, including A1c testing approximately 3 months after discontinuation for patients with diabetes, is recommended
For example, the number of people without any commercial insurance coverage for Zepbound increased by over 14% in 2025
Tirzepatide showed stronger suppressive effects on gene expression than those with semaglutide and retatrutide
10.1002/(sici)1096-9861(19990111)403:2 3.0.co;2-5 43 Mietlicki-BaaseE
We want you to feel confident, informed, and fully supported before you even open your medication box
Brad Stanfields rationale and what it signals about the future What actually works right now the unsexy, proven, no-prescription answer to GLP-1 drugs and muscle loss The bigger picture are GLP-1 drugs becoming geroprotectors